Table 2.

Effects of Nano-CUR on blood lipid peroxide (LPO) and total antioxidant capacity (TAC) as well as liver and kidney malondialdehyde (MDA) and reduced glutathione (GSH) in TZ-ingested rats.

Organs	Blood		Liver		Kidneys
Parameters → Groups ↓	TAC mM/L	LPO mg/100 mL	MDA n mole/mg Protein	GSH n mole/mg Protein	MDA n mole/mg Protein	GSH n mole/mg Protein
G1	68.31 ± 4.21	29.31 ± 0.83	5.11 ± 0.08	354.3 ± 2.06	6.34 ± 0.05	348.3 ± 2.51
G2	45.62 ** ± 6.31	35.6 ** ± 4.21	6.63 ** ± 0.03	296.01 ** ± 4.31	8.1 ** ± 0.07	267.7 ** ± 4.21
G3	70.11 ± 2.31	28.6 ± 3.11	4.81 ± 0.07	355.6 ± 2.81	5.11 ± 0.02	352.1 ± 5.23
G4	65.63 ± 4.21	26.61 ± 5.31	5.61 ± 0.06	341.6 ± 4.21	6.72 ± 0.04	343.7 ± 2.20
G5	67.63 ± 4.16	25.21 ± 7.32	4.92 ± 0.03	350.0 ± 2.09	5.61 ± 0.04	351.3 ± 4.32

Values are expressed as means ± SD, ** p < 0.01 relative to control (G1), TAC = Total Antioxidant Capacity, LPO = Lipid Peroxide, MDA = Malonaldehyde, GSH = Glutathione Reduced. Group1 = Control, Group2 = TZ-treatment, Group3 = Nano-CUR treatment, Group4 = 1 (g) Nano-CUR + 7.5 mg TZ Mix. Treatment, Group5 = 2 (g) Nano-CUR + 7.5 mg TZ Mix. Treatment.